Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide in Bipolar Disorder
NCT07286175Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of brenipatide in bipolar disorder (BD), sponsored by Eli Lilly and Company. Started Nov 2025; status: recruiting.
02
Drugs
brenipatide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT07286175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07286175.